Controlled Trial of Oxprenolol and Practolol in Hypertension
A. W. D. Leishman, J. L. Thirkettle, B.R. Allen, R. A. Dixon
Abstract
Open-access reader
A. W. D. Leishman, J. L. Thirkettle, B.R. Allen, R. A. Dixon
Abstract
Open-access reader
In controlled trials of the beta-adrenergic blocking drugs oxprenolol and practolol in hypertension both drugs were well tolerated without side effects and caused statistically significant non-postural reduction of blood pressure. In less than half the patients on eitherdrug the reduction of blood pressure was clinically adequate. No attempt was made to compare the two drugs.
OpenAlex reports 43 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In controlled trials of the beta-adrenergic blocking drugs oxprenolol and practolol in hypertension both drugs were well tolerated without side effects and caused statistically significant non-postural reduction of blood pressure. In less than half the patients on eitherdrug the reduction of blood pressure was clinically adequate. No attempt was made to compare the two drugs.
Key concepts: Oxprenolol, Practolol, Medicine, Blood pressure, Adrenergic beta-Antagonists, Pharmacology, Cardiology, Internal medicine